期刊文献+

甘露醇促进人脐血CD34^+细胞通过血脑屏障静脉迁移至高血压脑梗死大鼠脑组织 被引量:2

Mannitol improves the efficacy of intravenous transplantation of human umbilical cord blood CD34^+ cells for cerebral infarction in hypertensive rats
下载PDF
导出
摘要 背景:单纯脐血细胞经静脉移植治疗脑梗死疗效有限,移植细胞经血脑屏障迁入脑内数量不足为重要原因之一。目的:观察血脑屏障开放剂甘露醇对人脐血CD34+细胞经静脉移植治疗高血压大鼠脑梗死疗效的影响。方法:分离人脐血CD34+细胞,脂质体方法转染pEGFPF质粒,制备pEGFP-CD34+细胞;45只雄性SD大鼠经线栓法建立大脑中动脉栓塞模型,造模后24h随机分为3组:实验组注射1×106GFP-CD34+细胞,继之注射20%甘露醇2g/kg;阳性对照组注射1×106GFP-CD34+细胞;空白对照组注射等量生理盐水。结果与结论:①荧光显微镜下实验组每张切片脑组织GFP标记阳性的绿色荧光细胞计数平均值显著多于阳性对照组。②移植后第7天治疗组与其他各组神经功能损害评分差异无显著性意义;移植后28d,各组神经功能均有不同程度恢复,实验组神经功能恢复明显优于阳性对照组和空白对照组(P<0.05)。③实验组与其他两组相比,大鼠脑梗死体积均显著减少。④实验组脑组织匀浆胶质细胞源性神经营养因子水平较阳性对照组、空白对照组明显增高。提示血脑屏障开放剂甘露醇促进静脉移植CD34+细胞通过血脑屏障迁入至脑组织,并增强静脉移植CD34+细胞治疗脑梗死的疗效。 BACKGROUND:Intravenous transplantation of human umbilical cord blood cells(HUCBCs) in treatment of cerebral infarction is limited.Only a small fraction of the grafted cells appears to survive at the damaged brain and the behavioral recovery is only partial.OBJECTIVE:To evaluate the ability of Mannitol,a blood brain barrier(BBB) permeabilizer,to enhance neuroprotective effects of intravenously administered HUCBCs for cerebral infarction in spontaneous hypertensive rats.METHODS:CD34+ cells isolated from HUCB were transfected by GFP plasmid with liposome method.Forty-five adult male spontaneous hypertensive rats with middle cerebral artery occlusion were randomly divided into three groups at 24 hours after modeling,each of 15:Experimental group,GFP-CD34+ cells(1×106) and 20% Mannitol(2 g/kg) were administrated intravenously at 24 hours after modeling;Positive control group,GFP-CD34+ cells(1×106) were only injected intravenously at same time;Blank control group,normal saline was injected at same time.RESULTS AND CONCLUSION:①The number of GFP positive cells in cerebral tissues in the experimental group was increased significantly compared to the positive control group.②No significant difference was found in the neurologic function scores at day 7 after transplantation among the three groups;but at day 28 after transplantation,the neurologic function in the experimental group was improved significantly compared with the positive or blank control group(P〈0.05).③The cerebral infarct volume in the experimental group was significantly decreased compared with the positive or blank control group.④The glial cell line-derived neurotrophic factor level in cerebral tissue in the experimental group was significantly increased compared with the positive and blank control groups.The results suggested that Mannitol enhanced CD34+ cells to migrate into ischemic-injured cerebral tissues,and to improve the efficacy of CD34+ cells delivered intravenously for cerebral infarction in spontaneous hypertensive rats.
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2011年第27期5068-5071,共4页 Journal of Clinical Rehabilitative Tissue Engineering Research
基金 国家自然科学基金资助项目(30572079)~~
  • 相关文献

参考文献3

二级参考文献26

  • 1陈晓岚,黄仁彬,汤银娟,莫艳秀,刘科峰,刘运海.人脐血间充质干细胞静脉移植治疗大鼠局灶性脑缺血的实验研究[J].中国实用神经疾病杂志,2007,10(1):4-7. 被引量:10
  • 2Savitz SI, Dinsmore JH, Wechsler LR, et al. Cell therapy for stroke [ J ]. NeuroRx ,2004,1 (4) :406-414.
  • 3Chen J,Sanberg PR,Li Y,et al. Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats [ J ]. Stroke,2001,32 ( 11 ) :2682-2688.
  • 4Madkaikar M, Gupta M, Ghosh K, et al. Optimising methods of red cell sedimentation from cord blood to maximise nucleated cell recovery prior to cryopreservation [ J ]. Br J Biomed Sci, 2007,64 (4) : 157- 159.
  • 5Zea Longa E, Weistein PR, Calson S, et al. Reversible middle cerebral artery occlusion without craniectomy in rats[ J]. Stroke, 1989,20 ( 1 ) :84-88.
  • 6Bederson JB,Pitts LH,Tsuji M, et al. Rat middle cerebral artery occlusion evaluation of model and development of a neurologic examination [ J ]. Stroke, 1986,17 (3) :472-476.
  • 7Ha Y, Lee JE, Kim KN, et al. Intermediate filament nestin expressions in human cord blood monocytes[ J]. Acta Neurochir (Wien) ,2003, 145 ( 3 ) :425-429.
  • 8Borlongan CV, Hadman M, Sanberg CD, et al. Central nervous system entry of peripherally injected umbilical cord blood ceils is not required for neuroprotection 2in stroke [ J ]. Stroke, 2004, 35 ( 10 ) : 2385- 2389.
  • 9Yu G, Borlongan CV, Stahl CE, et al. Systemic delivery of umbilical cord blood cells for stroke therapy:A review[ J]. Res Neurol Neurosci ,2009,27 ( 1 ) :41-54.
  • 10Willing AE, Lixian J, Milliken M, et al. Intravenous versus intrastriatal cord blood administration in a rodent model of stroke [ J ]. J Neurosci Res ,2003,73 ( 3 ) :296-307.

共引文献10

同被引文献35

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部